Pmv Pharmaceuticals Net Income
| PMVP Stock | USD 1.11 0.03 2.78% |
As of the 14th of February 2026, Pmv Pharmaceuticals holds the Variance of 11.25, coefficient of variation of (1,822), and Risk Adjusted Performance of (0.04). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pmv Pharmaceuticals, as well as the relationship between them.
Analyzing historical trends in various income statement and balance sheet accounts from Pmv Pharmaceuticals' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Pmv Pharmaceuticals' valuation are summarized below:There are currently one hundred twenty trending fundamental ratios for Pmv Pharmaceuticals that can be evaluated and compared over time across competitors. Investors and active traders are advised to check out Pmv Pharmaceuticals' recent fundamental performance against the performance between 2010 and 2026 to make sure the trends are evolving in the right direction. As of 02/14/2026, Market Cap is likely to drop to about 85.1 M. In addition to that, Enterprise Value is likely to drop to about 41.7 M This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -52.8 M | -55.5 M | |
| Net Loss | -66 M | -69.3 M | |
| Net Loss | -52.8 M | -55.5 M | |
| Net Loss | (1.02) | (1.08) | |
| Net Income Per E B T | 0.90 | 1.07 |
Pmv | Net Income | Build AI portfolio with Pmv Stock |
Evaluating Pmv Pharmaceuticals's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Pmv Pharmaceuticals's fundamental strength.
Latest Pmv Pharmaceuticals' Net Income Growth Pattern
Below is the plot of the Net Income of Pmv Pharmaceuticals over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Pmv Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Pmv Pharmaceuticals operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Pmv Pharmaceuticals' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pmv Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (58.71 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Pmv Net Income Regression Statistics
| Arithmetic Mean | (34,399,065) | |
| Coefficient Of Variation | (61.99) | |
| Mean Deviation | 18,917,253 | |
| Median | (17,538,000) | |
| Standard Deviation | 21,322,978 | |
| Sample Variance | 454.7T | |
| Range | 55.8M | |
| R-Value | (0.84) | |
| Mean Square Error | 146T | |
| R-Squared | 0.70 | |
| Significance | 0.000029 | |
| Slope | (3,530,468) | |
| Total Sum of Squares | 7274.7T |
Pmv Net Income History
Other Fundumenentals of Pmv Pharmaceuticals
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Pmv Pharmaceuticals Net Income component correlations
Pmv Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Pmv Pharmaceuticals is extremely important. It helps to project a fair market value of Pmv Stock properly, considering its historical fundamentals such as Net Income. Since Pmv Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pmv Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pmv Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
Can Biotechnology industry sustain growth momentum? Does Pmv have expansion opportunities? Factors like these will boost the valuation of Pmv Pharmaceuticals. Anticipated expansion of Pmv directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Pmv Pharmaceuticals demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Understanding Pmv Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Pmv's accounting equity. The concept of intrinsic value - what Pmv Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Pmv Pharmaceuticals' price substantially above or below its fundamental value.
It's important to distinguish between Pmv Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pmv Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Pmv Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Pmv Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pmv Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pmv Pharmaceuticals.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in Pmv Pharmaceuticals on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Pmv Pharmaceuticals or generate 0.0% return on investment in Pmv Pharmaceuticals over 90 days. Pmv Pharmaceuticals is related to or competes with Immunic, Relmada Therapeutics, Acrivon Therapeutics, Vaxart, Biomea Fusion, Lite Strategy, and Cibus Global. PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and ... More
Pmv Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pmv Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pmv Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 17.05 | |||
| Value At Risk | (4.63) | |||
| Potential Upside | 6.36 |
Pmv Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pmv Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pmv Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Pmv Pharmaceuticals historical prices to predict the future Pmv Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.44) | |||
| Treynor Ratio | (0.27) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pmv Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pmv Pharmaceuticals February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.26) | |||
| Mean Deviation | 2.55 | |||
| Coefficient Of Variation | (1,822) | |||
| Standard Deviation | 3.35 | |||
| Variance | 11.25 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.44) | |||
| Treynor Ratio | (0.27) | |||
| Maximum Drawdown | 17.05 | |||
| Value At Risk | (4.63) | |||
| Potential Upside | 6.36 | |||
| Skewness | 0.4447 | |||
| Kurtosis | 0.5151 |
Pmv Pharmaceuticals Backtested Returns
Pmv Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.11, which implies the firm had a -0.11 % return per unit of risk over the last 3 months. Pmv Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pmv Pharmaceuticals' Coefficient Of Variation of (1,822), variance of 11.25, and Risk Adjusted Performance of (0.04) to confirm the risk estimate we provide. The company holds a Beta of 0.71, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pmv Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Pmv Pharmaceuticals is expected to be smaller as well. At this point, Pmv Pharmaceuticals has a negative expected return of -0.35%. Please make sure to check Pmv Pharmaceuticals' maximum drawdown and rate of daily change , to decide if Pmv Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.67 |
Good predictability
Pmv Pharmaceuticals has good predictability. Overlapping area represents the amount of predictability between Pmv Pharmaceuticals time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pmv Pharmaceuticals price movement. The serial correlation of 0.67 indicates that around 67.0% of current Pmv Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.67 | |
| Spearman Rank Test | 0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Pmv Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Pmv Pharmaceuticals reported net income of (58.71 Million). This is 117.2% lower than that of the Biotechnology sector and 183.82% lower than that of the Health Care industry. The net income for all United States stocks is 110.28% higher than that of the company.
Pmv Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pmv Pharmaceuticals' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pmv Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Pmv Pharmaceuticals by comparing valuation metrics of similar companies.Pmv Pharmaceuticals is currently under evaluation in net income category among its peers.
Pmv Pharmaceuticals Current Valuation Drivers
We derive many important indicators used in calculating different scores of Pmv Pharmaceuticals from analyzing Pmv Pharmaceuticals' financial statements. These drivers represent accounts that assess Pmv Pharmaceuticals' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Pmv Pharmaceuticals' important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 2.8B | 1.0B | 396.7M | 77.9M | 89.6M | 85.1M | |
| Enterprise Value | 2.4B | 881.4M | 302.4M | 38.2M | 43.9M | 41.7M |
Pmv Pharmaceuticals Institutional Holders
Institutional Holdings refers to the ownership stake in Pmv Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Pmv Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Pmv Pharmaceuticals' value.| Shares | Two Sigma Advisers, Llc | 2025-06-30 | 485.7 K | Peapod Lane Capital Llc | 2025-06-30 | 452.7 K | Geode Capital Management, Llc | 2025-06-30 | 432.7 K | Two Sigma Investments Llc | 2025-06-30 | 291.5 K | Assenagon Asset Management Sa | 2025-06-30 | 263.1 K | Citadel Advisors Llc | 2025-06-30 | 256.4 K | Rbf Llc | 2025-06-30 | 245.6 K | State Street Corp | 2025-06-30 | 157.6 K | Bridgeway Capital Management, Llc | 2025-06-30 | 148.8 K | Orbimed Advisors, Llc | 2025-06-30 | 6.5 M | Bml Capital Management Llc | 2025-06-30 | 5 M |
Pmv Fundamentals
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.32 | ||||
| Current Valuation | (70.85 M) | ||||
| Shares Outstanding | 53.21 M | ||||
| Shares Owned By Insiders | 3.30 % | ||||
| Shares Owned By Institutions | 68.50 % | ||||
| Number Of Shares Shorted | 1.85 M | ||||
| Price To Book | 0.49 X | ||||
| EBITDA | (73.67 M) | ||||
| Net Income | (58.71 M) | ||||
| Cash And Equivalents | 277.43 M | ||||
| Cash Per Share | 6.08 X | ||||
| Total Debt | 1.19 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 24.76 X | ||||
| Book Value Per Share | 2.28 X | ||||
| Cash Flow From Operations | (51.28 M) | ||||
| Short Ratio | 6.75 X | ||||
| Earnings Per Share | (1.59) X | ||||
| Price To Earnings To Growth | (0.31) X | ||||
| Target Price | 7.6 | ||||
| Number Of Employees | 47 | ||||
| Beta | 1.38 | ||||
| Market Capitalization | 57.47 M | ||||
| Total Asset | 191.29 M | ||||
| Retained Earnings | (368.71 M) | ||||
| Working Capital | 161.29 M | ||||
| Net Asset | 191.29 M |
About Pmv Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pmv Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pmv Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pmv Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Pmv Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pmv Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Pmv Stock
Moving against Pmv Stock
| 0.82 | DRTS | Alpha Tau Medical | PairCorr |
| 0.74 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.74 | DSGN | Design Therapeutics | PairCorr |
| 0.68 | SAB | Sonic Healthcare Earnings Call This Week | PairCorr |
| 0.65 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
The ability to find closely correlated positions to Pmv Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pmv Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pmv Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pmv Pharmaceuticals to buy it.
The correlation of Pmv Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pmv Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pmv Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pmv Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Pmv Stock Analysis
When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.